Healthcare -
Biotechnology - NASDAQ - US
$ 30.75
-0.646 %
$ 13.7 B
Market Cap
12.11
P/E
RPRX - CASH FROM OPERATIONS
Cash from Operations RPRX - Royalty Pharma plc
2.99 B
LAST VALUE
21.69%
2 YEAR CAGR
13.05%
5 YEAR CAGR
0.00%
10 YEAR CAGR